Humira pen 40 MG/0.8 MLS
Ended Awarded
- Contract number
- SPE2DR26FY8ES
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,788
Award facts
- Contract value 100% obligated
- $2,787.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,787.90 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This non-competitive, firm fixed-price delivery order was issued on November 17, 2025, with an ultimate completion date of November 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. As the prime contractor under the IDC, the company demonstrates extensive capability in fulfilling federal medical supply requirements through its portfolio of competitively awarded delivery orders spanning multiple therapeutic domains. This particular delivery order exemplifies the company's role in supplying brand-name medications and specialized pharmaceuticals to support the Defense Health Agency and other government healthcare systems through DLA's flexible and comprehensive contract vehicle.
Quick answers
Who was awarded contract SPE2DR26FY8ES?
SPE2DR26FY8ES was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FY8ES worth?
The government has obligated $2,788 on SPE2DR26FY8ES.
Is contract SPE2DR26FY8ES an order under another contract?
Yes. SPE2DR26FY8ES is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8ES competed?
The extent of competition for SPE2DR26FY8ES was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award